Xianghui Han

Longhua Hospital, Shanghai University of Traditional Chinese Medicine

Affiliated withShanghai University of Traditional Chinese Medicine

Research Area

Cancer Research

Biography

Xianghui Han has not added Biography.
If you are Xianghui Han and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 4	2022

Other Publications

Article	Year
A sensitive method for determination of platycodin d in rat plasma using liquid chromatography/tandem mass spectrometry and its application to a pharmacokinetic study. Planta medica\| PubMed ID: 22095263	2012
Psoralen inhibits bone metastasis of breast cancer in mice. Fitoterapia\| PubMed ID: 24060909	2013
Characterization of the attenuation of breast cancer bone metastasis in mice by zoledronic acid using (99m)Tc bone scintigraphy. Pathology oncology research : POR\| PubMed ID: 24610002	2014
Osthole inhibits bone metastasis of breast cancer. Oncotarget\| PubMed ID: 28938572	2017
Adipocytokines and breast cancer. Current problems in cancer\| PubMed ID: 29433827	2018
Comparative pharmacokinetics of six coumarins in normal and breast cancer bone-metastatic mice after oral administration of Wenshen Zhuanggu Formula. Journal of ethnopharmacology\| PubMed ID: 29803570	2018
Wenshen Zhuanggu formula mitigates breast cancer bone metastasis through the signaling crosstalk among the Jagged1/Notch, TGF-β and IL-6 signaling pathways. Journal of ethnopharmacology\| PubMed ID: 30576770	2019
Efficacy and safety of olaparib maintenance therapy in platinum-sensitive ovarian cancer patients with mutations: a meta-analysis on randomized controlled trials. Cancer management and research\| PubMed ID: 31114351	2019
CSCs in Breast Cancer-One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs. Cancers\| PubMed ID: 31394796	2019
The crosstalk between STAT3 and p53/RAS signaling controls cancer cell metastasis and cisplatin resistance via the Slug/MAPK/PI3K/AKT-mediated regulation of EMT and autophagy. Oncogenesis\| PubMed ID: 31597912	2019
WSZG inhibits BMSC-induced EMT and bone metastasis in breast cancer by regulating TGF-β1/Smads signaling. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 31810139	2020
Saikosaponin A Inhibits Triple-Negative Breast Cancer Growth and Metastasis Through Downregulation of CXCR4. Frontiers in oncology\| PubMed ID: 32047724	2019
Proteomics analysis of tumor exosomes reveals vital pathways of Jinfukang inhibiting circulating tumor cells metastasis in lung cancer. Journal of ethnopharmacology\| PubMed ID: 32240782	2020
Ruyiping extract reduces lung metastasis in triple negative breast cancer by regulating macrophage polarization. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie\| PubMed ID: 34246955	2021
Osthole inhibits the migration and invasion of highly metastatic breast cancer cells by suppressing ITGα3/ITGβ5 signaling. Acta pharmacologica Sinica\| PubMed ID: 34426644	2022
Luteolin Prevents Cardiac Dysfunction and Improves the Chemotherapeutic Efficacy of Doxorubicin in Breast Cancer. Frontiers in cardiovascular medicine\| PubMed ID: 34722681	2021
Development and validation of novel defined pyroptosis-related gene signature for progression-free survival prediction in patients with breast invasive carcinoma. Minerva surgery\| PubMed ID: 35147394	2022